Search
Showing results for "1"
News & Events
Turners turn out for ENDIA StudyAustralia’s largest study into the causes of type 1 diabetes reached a significant milestone when it recruited its first family in Perth with three children recently.
Research
Hypoglycaemia in DiabetesIatrogenic hypoglycaemia is one of the main limiting factors in the glycaemic management of diabetes. It causes negative biological, psychological, and social consequences in most people with type 1 diabetes and in many with advanced type 2 diabetes. This chapter explores physiological homeostatic mechanisms that prevent hypoglycaemia through glucose counter-regulation, before discussing specific acquired defects of glucose counter-regulation in diabetes, which provides an insight into risk factors for hypoglycaemia.
News & Events
Donated pump a blessing for KyeLooking at him now, it’s hard to believe busy one-year-old toddler Kye Gilbert was extremely unwell in Perth Children’s Hospital’s critical care unit with a new diagnosis of type 1 diabetes just a few months ago.
News & Events
Join our nutrition videosWould you like to help teach others with diabetes? The team at the Rio Tinto Children’s Diabetes Centre are creating nutrition education videos for children and their parents living with type 1 diabetes.
News & Events
Research participation surveyWe recognise that we can learn a lot from our families. This area of research looks at the reasons why families living with diabetes choose whether or not to participate in research.
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.
Research
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.
Research
Progression of early structural lung disease in young children with cystic fibrosis assessed using CTCross-sectional studies implicate neutrophilic inflammation and pulmonary infection as risk factors for early structural lung disease in infants and young...
News & Events
Congratulations Kate and AveniFantastic news for two of our talented researchers whose papers were featured in the Advanced Technologies & Treatments for Diabetes (ATTD) 2024 Yearbook.